Skip to Main Content

Author Details

Lisanne F van Dessel
Erasmus MC Cancer Institute
2015
11
8
PMIDPaper TitleJournal TitlePublished Year
3397456011-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration.JCI Insight2021
33761899Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer.BMC Cancer2021
33932725Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.Eur J Cancer2021
34670587High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.Clin Epigenetics2021
34006333Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patients.Genome Med2021
32675591Fundamentals of liquid biopsies in metastatic prostate cancer: from characterization to stratification.Curr Opin Oncol2020
30516338High-throughput isolation of circulating tumor DNA: a comparison of automated platforms.Mol Oncol2019
31748536The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact.Nat Commun2019
30014044Salvage radiotherapy after radical prostatectomy: Long-term results of urinary incontinence, toxicity and treatment outcomes.Clin Transl Radiat Oncol2018
28164427Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.Mol Oncol2017
26060190Reversibility of neuropathology and motor deficits in an inducible mouse model for FXTAS.Hum Mol Genet2015
  • 1 - 11 of 11

Recommended Authors

University of British Columbia
Career Start Year 2018
Number of shared co-authors 5
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2018
Number of shared co-authors 3
University of British Columbia
Career Start Year 2017
Number of shared co-authors 1
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 0
Personal Genome Diagnostics Inc.
Career Start Year 2016
Number of shared co-authors 0
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 2
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2014
Number of shared co-authors 0
Theageneion Anticancer Hospital
Career Start Year 2013
Number of shared co-authors 1
Decipher Biosciences Inc.
Career Start Year 2013
Number of shared co-authors 0
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 1
University of British Columbia
Career Start Year 2011
Number of shared co-authors 6
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 7
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 1
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 1
The Institute of Cancer Research
Career Start Year 2008
Number of shared co-authors 1
Peter MacCallum Cancer Centre
Career Start Year 2007
Number of shared co-authors 2
University of British Columbia
Career Start Year 2007
Number of shared co-authors 5
Veracyte Inc.
Career Start Year 2006
Number of shared co-authors 3
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 2004
Number of shared co-authors 5
Prostate Cancer Clinical Trials Consortium (PCCTC)
Career Start Year 2004
Number of shared co-authors 0
University of California San Francisco
Career Start Year 2003
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 2002
Number of shared co-authors 2
19University of Wisconsin Carbone Cancer Center.
Career Start Year 2000
Number of shared co-authors 2
Massachusetts General Hospital
Career Start Year 2000
Number of shared co-authors 2
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Career Start Year 1997
Number of shared co-authors 6
UCSF Medical Center-Mount Zion
Career Start Year 1997
Number of shared co-authors 11
The Institute of Cancer Research
Career Start Year 1993
Number of shared co-authors 2

Collaborators

Erasmus MC Cancer Institute
Co-authored papers 9
Erasmus Medical Center (MC) Cancer Institute
Co-authored papers 8
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 6
Erasmus MC Cancer Institute
Co-authored papers 4
Erasmus MC Cancer Institute
Co-authored papers 3
Franciscus Gasthuis & Vlietland Hospital Rotterdam and Schiedam
Co-authored papers 3
Department of Immunology Erasmus University Medical Center
Co-authored papers 2
University of California los angeles
Co-authored papers 1
The Netherlands Cancer Institute
Co-authored papers 1
Radboud university medical center
Co-authored papers 1
the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
Co-authored papers 1
Erasmus University Medical Center
Co-authored papers 1
Radboud University Medical Center
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Co-authored papers 1
The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital
Co-authored papers 1
Radboud University Medical Center
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers 1
Jiangsu Collaborative Innovation Center for Solid Organic Waste Resource Utilization
Co-authored papers 1
Hartwig Medical Foundation
Co-authored papers 1
Netherlands Cancer Institute-Antoni Van Leeuwenhoek
Co-authored papers 1